Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab vs Risedronate in Postmenopausal Osteoporosis
NCT00919711Phase 3Completed
- Sponsor
- Amgen
- Start
- Sep 2009
- Primary completion
- Dec 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 3 trial of denosumab in osteoporosis, sponsored by Amgen. Started Sep 2009; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00919711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00919711.